Skip to main content
Cureus logoLink to Cureus
. 2024 Feb 21;16(2):e54594. doi: 10.7759/cureus.54594

Non-Habit-Related Oral Squamous Cell Carcinoma: A Review

Rosalyn Lalremtluangi 1,, Suwarna Dangore-Khasbage 1
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10959472  PMID: 38523993

Abstract

Oral squamous cell carcinoma (OSCC) is a serious and potentially life-threatening condition that can have a profound impact on an individual’s health and well-being. Its etiology is commonly known to be habit induced, such as tobacco consumption, smoking, or alcohol abuse. Apart from these etiologies, certain factors that lead to OSCC are also present but are less frequently encountered in hospitals and clinics. However, these non-habitual factors, with their pathogenesis, can lead to OSCC, which may be confusing to certain medical practitioners. This article discusses the various non-habitual causes that can lead to OSCC, as well as their pathophysiology, molecular expression, and related indicators and prognostic factors.

Keywords: immunosuppressive, prognosis, oropharyngeal, carcinoma, biomarkers

Introduction and background

Oral squamous cell carcinoma (OSCC) is the most common variety of malignancies in the head and neck region [1,2], and it poses a serious threat to the life quality of people who are suffering from it. According to data obtained from the Global Cancer Observatory, the annual incidence of OSCC in 2020 was 377,713 cases worldwide, with Asia being the highest among other continents [3,4]. Habits such as tobacco use, alcohol intake, and smoking are the leading causes of OSCC, accounting for at least 80% of cases [5]. Tobacco contains numerous harmful substances, which may include nitrosamine, acrolein, carbon monoxide, formaldehyde, and polonium-210, all of which, through chronic irritation and inflammation of the oral mucosa, may cause the formation of premalignant lesions that may eventually lead to oral malignancy [6]. Both drinking and smoking are independently and synergistically linked to an increased risk of developing oral cancer, and the risks typically rise with greater exposure. Despite the growing awareness about the benefits of quitting tobacco, smoking, and drinking, the number of occurrences of oral malignancies has not declined much [7].

Nevertheless, OSCC, which occurs without any deleterious oral habits, has also been reported in the literature. According to recent research in 2019 by Saxena et al., 4-6% of oral cancer incidences are not associated with any oral habits in the Indian subcontinent [8]. Several etiologic factors may be present that cause OSCC without any oral habits. Age and gender predilection have been reported, along with conditions like hereditary and genetics, food habits, ultraviolet (UV) light, human papillomavirus (HPV) infection (where evidence of an elevated HPV DNA positive of 20-64% in oral lesions could be premalignant), and immune suppression, which are believed to be the non-habitual causes of the lesion [8,9]. The bulk of studies in past years did not make it quite clear as to which factors may trigger or cause OSCC in a non-habitual patient. As a result, this article aims to review the various non-habitual factors that can potentially lead to OSCC, along with their pathogenesis, markers, molecular expression, and prognostic aspects.

Review

Non-habitual factors related to OSCC

Age

Regarding the age group that is most frequently impacted by non-habit-related OSCC, there are conflicting statistics available [10]. While some writers claim that non-habit-related OSCC frequently affects young people, others claim that the age of susceptibility is bimodal globally, i.e., between 40 and 70. However, this situation deviates from the bimodal age predilection [11]. The earlier age at which non-habit-associated OSCC develops is thought to be influenced by genetic predisposition, viral etiology, phagocytic diseases, Fanconi anemia (FA), and environmental toxins [11]. The cumulative effect of dietary and environmental carcinogens is thought to make older people more prone to cancer [12]. Given the patient’s advanced age, frequent trauma in this situation could act as a mutagen, kicking off carcinogenesis in a favorable oral environment [13].

Gender

For oral cancer without a history of habits, women are more likely to develop it worldwide as compared to men. Male predilection is more associated with habit-induced OSCC [14]. It is well known that cancer cell lines originating from head and throat malignancies have genes involved in the metabolism of estrogen, especially estradiol, in tongue cancer. In females with non-habit-related OSCC, other research has linked altered levels of luteinizing hormone, follicle-stimulating hormone, prolactin, and testosterone [14]. This case widens the gaps in knowledge regarding the precise function of estrogen receptors in non-habit-associated OSCC, which appears to favor females [15].

Hereditary

Despite the fact that OSCCs are rare in communities, epidemiological research has indicated that there may be inherited risks for OSCCs. Studies have shown that the autosomal dominant mode of inheritance is seen in 0.94% of total oral cancer in India. Nevertheless, little is known about the genetic predispositions that lead to OSCCs. VAV2 and IQGAP1 were found to be the genetic causes of an oral cancer case in a family by Huang et al. In the family with oral cancer, both genes showed heterozygous mutations and were inherited autosomal dominantly [16]. According to a case study by Jeong et al., there is a little girl with OSCC whose mother had OSCC in her family history. It was discovered that the patient’s mother also carried the germline mutation CDKN2A c.301G>T [17]. As a result, germline mutations may be very important in the development of OSCC. It is thought that the rare hereditary condition known as FA increases the risk of head and neck squamous cell carcinomas by 200-800 times [18]. The incapacity of FA to heal DNA interstrand cross-links is one of its defining characteristics. Treatment for OSCC in FA is challenging since patients are not tolerant of the available treatments, which include platinum-based chemotherapy and ionizing radiation. In FA, the majority of tumors are found at an advanced stage [19].

Nutrition and Diet

Foods may directly cause cancer through the carcinogens they contain, or they may indirectly cause cancer through the metabolism’s production of carcinogens. de Oliveira Bezerra et al. state that 11-15% of oral and pharyngeal malignancies globally are caused by disequilibrium and/or a food deficit [20,21]. The majority of individuals eat a wide range of foods that provide a variety of nutrients, and their dietary habits frequently alter throughout time in response to cultural and socioeconomic factors [21]. An eating pattern that includes a lot of animal-based foods, fats, sugars, processed foods, and relatively little complex carbs and fiber has gradually replaced “traditional” eating patterns based on the consumption of grains and cereals due to the so-called “nutritional transition” [22]. These eating habits are thought to be potentially beneficial for the development of oropharyngeal cancer. Consuming animal fat-rich foods (dairy products, processed meats, and a variety of meats) and high-fat sauces has been positively linked to an elevated risk of OSCC [23]. An increased risk of mouth cancer has also been linked to a low fruit and vegetable diet. Certain vitamins, like vitamin E, have been linked to a decreased risk of cancer because they include substances like tocopherol, which has anti-inflammatory and antioxidant properties. However, there is no evidence that the vitamins B1, B5, B6, and K can prevent oral cancer [23].

Physical Carcinogens

UV exposure to sunlight is a potent etiological and predisposing factor for OSCC in a non-habitual patient. Jobs that include working outside and being in the sun for extended periods of time are more likely to cause OSCC on the lips. The incidence of OSCC due to UV radiation is estimated to be 3.33 or 3.94 per 100,000 individuals worldwide [24]. Effective defense systems have been developed to shield epidermal keratinocytes from UV-induced tumor development. These rely on signaling pathways that cause apoptosis to be induced [25]. However, because of the deregulation of these pathways, SCC cells have acquired certain traits [26]. UV light can cause inhibition of the apoptosis process, and as a result, the apoptosis deficit seems more important than increased proliferation overall. The most important causes of inhibition of apoptosis may be COX-2 activation, reactive oxygen species production, and p53 inactivation [27].

Ionizing radiation is also known to cause mutagenesis, which may include X-rays, beta, alpha, and gamma radiation, as well as radioactive isotopes. There are several studies regarding X-rays that indicate an increased chance of developing oral cancer due to their exposure [28]. Ionizing radiation is potent enough to break free electrons from atoms that are firmly bonded, damaging DNA and perhaps causing mutations that aid in the development of cancer. Dental X-rays are a common source of exposure to ionizing radiation in the oral cavity. Oral cancer risk may rise with frequent or high-dose exposure to ionizing radiation, particularly in medical settings, even if the doses from routine dental X-rays are generally thought to be modest and the risk is minimal [28,29]. The diagnostic benefits of X-rays, including the detection of dental issues and oral or other medical conditions, are often considered to outweigh the potential risks that can cause radiation exposure [29]. Healthcare professionals adhere to standard protocol to ensure that radiation exposure is maintained as low as reasonably attainable in order to minimize the risk of radiation-induced mouth cancer. This entails employing thyroid collars and lead aprons to protect non-imageable regions and utilizing the lowest feasible radiation dosage for medical evaluations [30].

Biological Carcinogens

HPV has been linked to a number of malignancies in humans, including those in the head and neck, vulvar, vaginal, penile, and cervical regions. The incidence of OSCC with a positive HPV infection has risen from less than 20% to more than 70% globally. Low-risk HPVs, such as HPV6 and HPV11, cause benign warts, while high-risk HPVs, such as HPV16 and HPV18, cause premalignant squamous intraepithelial neoplasia that can progress to malignant lesions. It is unclear how OSCC related to HPV behaves clinically [31]. For men under 50, the incidence of OSCC linked to HPV has sharply increased. A recent report given by Mirghani et al. showed a 17.5% positivity for high-risk HPVs in oral epithelial dysplasias using in situ hybridization and immunohistochemical staining against p16INK4A, a hallmark of infection by a biologically active virus [32]. People who have oral cancer caused by HPV are less likely to smoke or drink, and their prognosis is usually favorable. The floor of the mouth (9-42%) and the tongue (8-25%) appear to be the most common areas of HPV infection, despite frequency variations across research [33,34].

Epstein-Barr virus (EBV), which is a member of the herpesvirus family, has also been linked to the development of certain malignancies, including lymphomas and nasopharyngeal carcinoma [35]. In contrast to its participation in other malignancies, the correlation between EBV and OSCC is less evident. Research has suggested a potential connection between EBV and oral cancer, particularly in specific subsets of patients. While the precise methods by which EBV may aid in the development of oral cancer remain incompletely known, several investigations have found EBV in the tissues of oral cancer patients, indicating that the virus may be involved in the initiation or advancement of specific cases of mouth cancer [36]. It may contribute to oral malignancy by promoting genetic instability or affecting immune responses. The malignancy of EBV is associated with a number of proteins found in the viruses that regulate immune response, cell apoptosis, and cell proliferation [37]. Latent membrane proteins help in activating the signaling pathway, whereas the nuclear antigens of EBV help in gene expression. The impact of EBV on oral mucosal carcinogenesis, however, is still unknown because different methods, such as PCR, nested PCR, RT-qPCR, IHC, and ISH, are used to detect the virus [37]. The sensitivity and specificity of these tests vary depending on the method employed, which results in varying relationships between EBV infection and OSCC [38].

Oral Lichen Planus (OLP)

OLP is a chronic inflammatory T cell-mediated disease that mostly affects the tongue and buccal mucosa. Although the etiology is clearly unknown, T lymphocyte autoreaction may be of primary importance for the progression of OLP. These cells cannot differentiate between foreign antigens and inherent molecules of the body [39]. Stress, systemic medications such as beta-blockers, nonsteroidal anti-inflammatory drugs, antimalarials, diuretics, oral hypoglycemics, and penicillamine, oral retroviral medications, hypersensitivity to dental materials, chronic liver disease and hepatitis C virus, and graft-versus-host disease are also believed to cause OLP [40]. Over the past years, it has been clear that the immune system plays a major part in the onset of this illness. The histopathologic features of a subepithelial infiltration dominated by T lymphocytes and macrophages, as well as the degeneration of basal cells known as liquefaction degeneration, corroborate this [40]. These characteristics can be understood as a manifestation of the immune system’s cell-mediated component contributing to the etiology of OLP by means of T-lymphocyte cytotoxicity targeted at antigens produced by the basal cell layer. Clinical symptoms may include red and white elements, together with different textures and clinical types, which may include reticular, papular, plaque-like, bullous, erythematous, and ulcerative [41].

The foremost incidence of OLP malignant transformation was reported in 1910. A recent meta-analysis reported that 1.1% of lesions of OLP evolve into OSCC worldwide, where a higher frequency among hepatitis C virus-positive individuals was seen [41]. Tampa et al.’s research reveals a number of biomarkers that, when present, induce OLP to proceed to OSCC. These include variables that modulate apoptosis (p53 and MCL-1), cell cycle regulators (BMI1 and p16), tissue remodeling factors (MMPs), and factors related to inflammation (TNF-α, IL-6, and COX-2) [39]. The type of OLP that appears to change into OSCC most frequently is erosive and erythematous OLP. This could be due to the lack of protective mechanisms in the mucosa in erosive and erythematous OLP, unlike other types of OLP where there is keratinization as a defense reaction to stimulus. This lack of a defense system in erosive and erythematous OLP could lead to more rapid and aggressive subepithelial changes as compared to other types, which eventually could cause oral malignancy [42,43]. Malignant transformation most frequently happens in localized tongue lesions. According to Andabak-Rogulj et al., OLP lesions require an average of five and a half years to evolve into an established OSCC [44].

Immune System Suppression

Tumor cells have the ability to create a variety of immunosuppressive chemicals, such as regulatory T cells, tumor-associated macrophages, tumor-associated neutrophils, and cancer-associated fibroblasts [45]. These substances can impede the immune cells’ natural ability to fight cancer. When compared to non-immunosuppressed patients, immunosuppression has been shown to approximately double the risk of cancer-specific outcomes (such as recurrence and overall survival). Additionally, immunosuppression has a substantial correlation with poor outcomes in OSCC, with a risk of 0.2-1% [46]. Tumor cells can evade immune surveillance and tumor immunity through immunosuppressive mechanisms facilitated by their contact with immune cells. This ultimately advances the cancerous process. There was a significant correlation observed between the prognosis of OSCC in immunosuppressed patients and 11 immunosuppressive genes: CXCL8, TLR3, IL22, ORMDL3, FGFR3, CTLA4, HPRT1, BGLAP, CALCA, SPHK1, and INHBB [47]. Two survival subtypes, one with a lower chance of survival and the other with a higher probability of survival, were distinguished between OSCC patients using a deep learning-based model. A number of signaling pathways implicated in immunosuppression (such as T cell and B cell receptor signaling, p53, Notch, JAK-STAT, and MAPK) that are enriched in the aggressive subtype of OSCC have been identified as potential therapeutic targets. These pathways may be useful in treating immunosuppressed patients with OSCC and enhancing overall survival in particular patient populations [48].

Trauma

Apart from the oral habits that are commonly known to cause OSCC, an increased risk of oral cancer may be attributed to chronic inflammation due to poor dental hygiene, sharp edges from damaged teeth, or prolonged irritation from stimulation such as ill-fitting dentures. A report given by Pentenero et al. revealed that 44% of OSCC on the tongue showed signs of mechanical trauma. The risk of oral malignancy may also be higher in people who participate in practices that cause repeated stress to the oral cavity, such as biting the oral mucosa on a regular basis [49].

When in direct interaction with an agent that is mechanical, such as teeth or a denture, during functional or parafunctional movements or in the decubitus posture, the presence of chronic and persistent mechanical irritation can result in erythema, atrophy, ulceration, keratosis, hyperplasia, indentation, or fibrosis. Since most of the mucosal surfaces in the oral cavity have physiological contact with teeth or dentures when moving functionally or when at rest, it is easy to see that there is the necessary straight contact between the lesion and the traumatic agent. This is especially true when OSCC is present, which frequently indicates altered surfaces of mucosa because of an increased volume [50]. Through mechanisms that involve the interruption of the extracellular matrix’s normal architecture, which promotes expression of oncogenes, status of hyperproliferation, favorable inflammatory microenvironment, and enabled exposure to carcinogens, a potential protagonist for chronic trauma in the process of carcinogenesis has been suggested [51].

Conclusions

OSCC is a common malignancy in the head and neck region, usually caused by deleterious habits. However, apart from these habits, several non-habit-induced OSCCs are also present, which have not been thoroughly recognized in society. Understanding the multifaceted nature of non-habit-induced OSCC requires a holistic approach that considers genetic, viral, immunological, environmental, hormonal, and psychosocial factors. Also, OSCC could be prevalent in certain people with occupations that require long-span exposure to sunlight. Chronic irritation from traumatizing objects such as improperly fitted dentures, impinging dental restorations, pointed cusps, and root fragments can also cause damage to the oral cavity, potentially leading to OSCC. This reveals the challenging aspect of oral cancer that requires ongoing investigation and a multidisciplinary approach to enhance the ability to prevent, diagnose, and treat this condition effectively in patients without oral habits. Collaborative efforts between clinicians, researchers, and public health initiatives are essential. Through continued research and partnership, the medical community can strive toward a more comprehensive understanding of non-habit-induced OSCC and ultimately improve outcomes for affected individuals.

The authors have declared that no competing interests exist.

Author Contributions

Concept and design:  Rosalyn Lalremtluangi, Suwarna Dangore-Khasbage

Acquisition, analysis, or interpretation of data:  Rosalyn Lalremtluangi, Suwarna Dangore-Khasbage

Drafting of the manuscript:  Rosalyn Lalremtluangi, Suwarna Dangore-Khasbage

Critical review of the manuscript for important intellectual content:  Rosalyn Lalremtluangi, Suwarna Dangore-Khasbage

Supervision:  Rosalyn Lalremtluangi, Suwarna Dangore-Khasbage

References

  • 1.Independent and joint effects of tea and milk consumption on oral cancer among non-smokers and non-drinkers: a case-control study in China. Chen F, Yan L, Lin L, et al. Oncotarget. 2017;8:50091–50097. doi: 10.18632/oncotarget.15096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Oral cancer - the fight must go on against all odds. Ali K. Evid Based Dent. 2022;23:4–5. doi: 10.1038/s41432-022-0243-1. [DOI] [PubMed] [Google Scholar]
  • 3.Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Morse DE, Psoter WJ, Cleveland D, Cohen D, Mohit-Tabatabai M, Kosis DL, Eisenberg E. Cancer Causes Control. 2007;18:919–929. doi: 10.1007/s10552-007-9026-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Laryngoscope. 1999;109:1544–1551. doi: 10.1097/00005537-199910000-00002. [DOI] [PubMed] [Google Scholar]
  • 5.Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ. Oral Dis. 2007;13:239–243. doi: 10.1111/j.1601-0825.2006.01274.x. [DOI] [PubMed] [Google Scholar]
  • 6.Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Oral Oncol. 2001;37:401–418. doi: 10.1016/s1368-8375(00)00135-4. [DOI] [PubMed] [Google Scholar]
  • 7.Oral cancer incidence and mortality in China, 2011. Zhang SK, Zheng R, Chen Q, Zhang S, Sun X, Chen W. Chin J Cancer Res. 2015;27:44–51. doi: 10.3978/j.issn.1000-9604.2015.01.03. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Non-habit related oral squamous cell carcinoma: possible etiologic factors and probable prevention in Indian scenario. Saxena S, Kumar S. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;1:90. [Google Scholar]
  • 9.Human papilloma virus (HPV)-associated oral cancers and treatment strategies. Sathish N, Wang X, Yuan Y. J Dent Res. 2014;93:29–36. doi: 10.1177/0022034514527969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Oral squamous cell carcinoma frequency in young patients from referral centers around the world. Costa RF, Leão ML, Sant'Ana MS, et al. Head Neck Pathol. 2022;16:755–762. doi: 10.1007/s12105-022-01441-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.A case of oral squamous cell carcinoma in a nontobacco habitué. Carvalho KM, Sawant PR, Dhupar A, Spadigam A. Int J Appl Basic Med Res. 2017;7:278–280. doi: 10.4103/ijabmr.IJABMR_417_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Environmental factors inducing human cancers. Parsa N. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521879/ Iran J Public Health. 2012;41:1–9. [PMC free article] [PubMed] [Google Scholar]
  • 13.Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Feitelson MA, Arzumanyan A, Kulathinal RJ, et al. Semin Cancer Biol. 2015;35 :25–54. doi: 10.1016/j.semcancer.2015.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sex hormones and inflammation role in oral cancer progression: a molecular and biological point of view. Contaldo M, Boccellino M, Zannini G, et al. J Oncol. 2020;2020:14. doi: 10.1155/2020/9587971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Garcia M, Derocq D, Freiss G, Rochefort H. Proc Natl Acad Sci U S A. 1992;89:11538–11542. doi: 10.1073/pnas.89.23.11538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Identification of novel genetic variants predisposing to familial oral squamous cell carcinomas. Huang Y, Zhao J, Mao G, et al. Cell Discov. 2019;5:57. doi: 10.1038/s41421-019-0126-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report. Jeong AR, Forbes K, Orosco RK, Cohen EE. J Otolaryngol Head Neck Surg. 2022;51:5. doi: 10.1186/s40463-022-00556-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Oral squamous cell carcinoma in a patient with fanconi anemia. Huuhka M, Turunen A. Case Rep Dent. 2021;2021:5571649. doi: 10.1155/2021/5571649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Early diagnosis of oral cancer and lesions in fanconi anemia patients: a prospective and longitudinal study using saliva and plasma. Errazquin R, Carrasco E, Del Marro S, et al. Cancers. 2023;15:1871. doi: 10.3390/cancers15061871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Value of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue. Fang Q, Li P, Qi J, Luo R, Chen D, Zhang X. Laryngoscope. 2019;129:2527–2530. doi: 10.1002/lary.27927. [DOI] [PubMed] [Google Scholar]
  • 21.Diet and squamous cell carcinoma of the oral cavity and pharynx: a case-control study. de Oliveira Bezerra KF, de Oliveira DW, Menezes-Silva R, et al. https://www.redalyc.org/pdf/637/63749543069.pdf Pesqui Bras. 2017;17:1–3. [Google Scholar]
  • 22.Association between oral cancer and diet: an update. Rodríguez-Molinero J, Migueláñez-Medrán BD, Puente-Gutiérrez C, Delgado-Somolinos E, Martín Carreras-Presas C, Fernández-Farhall J, López-Sánchez AF. Nutrients. 2021;13:1299. doi: 10.3390/nu13041299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Red meat, micronutrients and oral squamous cell carcinoma of Argentine adult patients. Secchi DG, Aballay LR, Galíndez MF, Piccini D, Lanfranchi H, Brunotto M. Nutr Hosp. 2015;32:1214–1221. doi: 10.3305/nh.2015.32.3.9277. [DOI] [PubMed] [Google Scholar]
  • 24.UV-induced squamous cell carcinoma-a role for antiapoptotic signalling pathways. Rodust PM, Stockfleth E, Ulrich C, Leverkus M, Eberle J. Br J Dermatol. 2009;161 :107–115. doi: 10.1111/j.1365-2133.2009.09458.x. [DOI] [PubMed] [Google Scholar]
  • 25.UV radiation and the skin. D'Orazio J, Jarrett S, Amaro-Ortiz A, Scott T. Int J Mol Sci. 2013;14:12222–12248. doi: 10.3390/ijms140612222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches. Fania L, Didona D, Di Pietro FR, et al. Biomedicines. 2021;9:171. doi: 10.3390/biomedicines9020171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Molecular mechanisms of UV-induced apoptosis and its effects on skin residential cells: the implication in UV-based phototherapy. Lee CH, Wu SB, Hong CH, Yu HS, Wei YH. Int J Mol Sci. 2013;14:6414–6435. doi: 10.3390/ijms14036414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Early life ionizing radiation exposure and cancer risks: systematic review and meta-analysis. Abalo KD, Rage E, Leuraud K, Richardson DB, Le Pointe HD, Laurier D, Bernier MO. Pediatr Radiol. 2021;51:45–56. doi: 10.1007/s00247-020-04803-0. [DOI] [PubMed] [Google Scholar]
  • 29.Cancer risk of low dose ionizing radiation. Ali YF, Cucinotta FA, Ning-Ang L, Zhou G. Front. Phys. 2020;12:234. [Google Scholar]
  • 30.Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses. Little MP, Wakeford R, Bouffler SD, Abalo K, Hauptmann M, Hamada N, Kendall GM. Environ Int. 2022;159:106983. doi: 10.1016/j.envint.2021.106983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Andrews E, Seaman WT, Webster-Cyriaque J. Oral Oncol. 2009;45:486–491. doi: 10.1016/j.oraloncology.2008.07.008. [DOI] [PubMed] [Google Scholar]
  • 32.Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Mirghani H, Amen F, Moreau F, Lacau St Guily J. Oral Oncol. 2015;51:229–236. doi: 10.1016/j.oraloncology.2014.11.011. [DOI] [PubMed] [Google Scholar]
  • 33.HPV and cancer of the oral cavity. Hübbers CU, Akgül B. Virulence. 2015;6:244–248. doi: 10.1080/21505594.2014.999570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Detection of high-risk human papillomavirus in oral cavity squamous cell carcinoma using multiple analytes and their role in patient survival. Palve V, Bagwan J, Krishnan NM, et al. J Glob Oncol. 2018;4:1–33. doi: 10.1200/JGO.18.00058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Epstein-barr virus (EBV) epithelial associated malignancies: exploring pathologies and current treatments. Shechter O, Sausen DG, Gallo ES, Dahari H, Borenstein R. Int J Mol Sci. 2022;23:14389. doi: 10.3390/ijms232214389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.The Epstein-Barr virus and its association with human cancers. Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG. Mol Pathol. 1999;52:307–322. doi: 10.1136/mp.52.6.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.The association of Epstein-Barr virus with cancer. Patel PD, Alghareeb R, Hussain A, Maheshwari MV, Khalid N. Cureus. 2022;14:26314. doi: 10.7759/cureus.26314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Epstein-barr virus epithelial cancers-a comprehensive understanding to drive novel therapies. Han S, Tay JK, Loh CJ, Chu AJ, Yeong JP, Lim CM, Toh HC. Front Immunol. 2021;12:734293. doi: 10.3389/fimmu.2021.734293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Markers of oral lichen planus malignant transformation. Tampa M, Caruntu C, Mitran M, et al. Dis Markers. 2018;2018:1959506. doi: 10.1155/2018/1959506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Oral lichen planus and oral squamous cell carcinoma share key oncogenic signatures. de Lanna CA, da Silva BN, de Melo AC, et al. Sci Rep. 2022;12:20645. doi: 10.1038/s41598-022-24801-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Oral lichen planus: malignant potential and diagnosis. Shirasuna K. Oral Sci. Int. 2014;11:1–7. [Google Scholar]
  • 42.Oral lichen planus: an update on etiology, pathogenesis, clinical presentation, diagnosis and management. Gupta S, Jawanda MK. Indian J Dermatol. 2015;60:222–229. doi: 10.4103/0019-5154.156315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Oral lichen planus: clinical features, etiology, treatment and management; a review of literature. Boorghani M, Gholizadeh N, Taghavi Zenouz A, Vatankhah M, Mehdipour M. J Dent Res Dent Clin Dent Prospects. 2010;4:3–9. doi: 10.5681/joddd.2010.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Different treatment modalities of oral lichen planus—a narrative review. Andabak-Rogulj A, Vindiš E, Aleksijević LH, Škrinjar I, Juras DV, Aščić A, Brzak BL. Dent J (Basel) 2023;11:26. doi: 10.3390/dj11010026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hallmarks of cancer expression in oral lichen planus: a scoping review of systematic reviews and meta-analyses. González-Moles MÁ, Keim-Del Pino C, Ramos-García P. Int J Mol Sci. 2022;23:13099. doi: 10.3390/ijms232113099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Molecular subtypes of oral squamous cell carcinoma based on immunosuppression genes using a deep learning approach. Li S, Mai Z, Gu W, et al. Front Cell Dev Biol. 2021;9:687245. doi: 10.3389/fcell.2021.687245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.PD-L1-mediated immunosuppression in oral squamous cell carcinoma: relationship with macrophage infiltration and epithelial to mesenchymal transition markers. Wu T, Tang C, Tao R, Yong X, Jiang Q, Feng C. Front Immunol. 2021;12:693881. doi: 10.3389/fimmu.2021.693881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.The immune cells in the development of oral squamous cell carcinoma. Caponio VC, Zhurakivska K, Lo Muzio L, Troiano G, Cirillo N. Cancers. 2023;15:3779. doi: 10.3390/cancers15153779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Chronic mechanical trauma/irritation and oral carcinoma: a systematic review showing low evidence to support an association. Pentenero M, Azzi L, Lodi G, Manfredi M, Varoni E. Oral Dis. 2022;28:2110–2118. doi: 10.1111/odi.14049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Chronic oral mucosal trauma and oral cancer: a series of cases. Thongprasom K, Phattarataratip E. https://www.scientificarchives.com/article/chronic-oral-mucosal-trauma-and-oral-cancer-a-series-of-cases Arch Dent Res. 2019;1:16–20. [Google Scholar]
  • 51.Correlation between chronic mucosal trauma and oral cancer: a case report and review of the literature. Mameli A, Murgia MS, Orrù G, Casu C. World Cancer Res J. 2021;8:1–5. [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES